- Home
- ERAS vs HKD Comparison
ERAS vs HKD Comparison
Compare ERAS & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- HKD
- Stock Information
- Founded
- ERAS 2018
- HKD 2003
- Country
- ERAS United States
- HKD France
- Employees
- ERAS N/A
- HKD N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- HKD Finance: Consumer Services
- Sector
- ERAS Health Care
- HKD Finance
- Exchange
- ERAS Nasdaq
- HKD Nasdaq
- Market Cap
- ERAS 719.0M
- HKD 689.8M
- IPO Year
- ERAS 2021
- HKD 2022
- Fundamental
- Price
- ERAS $2.67
- HKD $2.73
- Analyst Decision
- ERAS Strong Buy
- HKD
- Analyst Count
- ERAS 5
- HKD 0
- Target Price
- ERAS $6.10
- HKD N/A
- AVG Volume (30 Days)
- ERAS 1.7M
- HKD 309.2K
- Earning Date
- ERAS 11-12-2024
- HKD 01-01-0001
- Dividend Yield
- ERAS N/A
- HKD N/A
- EPS Growth
- ERAS N/A
- HKD N/A
- EPS
- ERAS N/A
- HKD 0.33
- Revenue
- ERAS N/A
- HKD $27,776,448.00
- Revenue This Year
- ERAS N/A
- HKD N/A
- Revenue Next Year
- ERAS N/A
- HKD N/A
- P/E Ratio
- ERAS N/A
- HKD $8.38
- Revenue Growth
- ERAS N/A
- HKD N/A
- 52 Week Low
- ERAS $1.51
- HKD $2.61
- 52 Week High
- ERAS $3.45
- HKD $6.18
- Technical
- Relative Strength Index (RSI)
- ERAS 43.56
- HKD 34.68
- Support Level
- ERAS $2.59
- HKD $3.00
- Resistance Level
- ERAS $3.19
- HKD $3.04
- Average True Range (ATR)
- ERAS 0.20
- HKD 0.19
- MACD
- ERAS -0.02
- HKD -0.05
- Stochastic Oscillator
- ERAS 20.13
- HKD 2.75
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.